Immunocompromised clinical trials at UC Davis
1 research study open to eligible people
Showing trials for
Investigating a potential treatment option for parainfluenza virus in immunocompromised patients
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to all eligible people
This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.
Sacramento, California and other locations
Our lead scientists for Immunocompromised research studies include Stuart Cohen, MD.